List

S.Suman1, P. Karthikeyan2, S.Moulishankar3,  S.Sridhar4, G. Raaja5*, G.S. Aathithiah6, M.Vetriselvan7, Joemon8, R.Pachiyappan9,  B. Devendran10

Authors:
1Managing Director, Vijayani Nutraceuticals Pvt Ltd, 2Director, Vijayani Nutraceuticals Pvt Ltd, 3Director, Vijayani Nutraceuticals Pvt Lt, 4  Principal Research Investigator, Ashram Siddha Research Institute, 5Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 6Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 7General Manager, Vijayani Nutraceuticals Pvt Ltd, 8Manufacturing Incharge, Vijayani Nutraceuticals Pvt Ltd, 9Product Development, Oriens Global Marketing Pvt Ltd, 10 Pharmacologist, Vijayani Nutraceuticals Pvt Ltd
Corresponding Author:
*Dr. G. Raaja, Medical Officer, Vijayani Nutraceuticals Pvt. Ltd., Chennai, Tamil Nadu, India.
Email ID: raaja.ayurdoctor@gmail.com

Abstract

Introduction: Obesity and hypercholesterolemia are significant global health concerns, contributing to metabolic disorders such as cardiovascular disease and type 2 diabetes. Conventional treatments often include pharmacological interventions and lifestyle modifications, which may have limitations in terms of adherence and side effects. Ayurvedic medicine offers a holistic approach to weight management and metabolic regulation. DELIPO CAPSULE, a proprietary Ayurvedic formulation, has been developed to address symptoms associated with obesity, including shortness of breath, fatigue, excessive sweating,, difficulty in sleeping and high LDL cholesterol levels.  Objective: The primary objective of this study was to evaluate the clinical efficacy of DELIPO CAPSULE in managing symptoms of obesity and hypercholesterolemia.

Methods: The study aimed to assess its impact on weight management, cholesterol levels, and associated symptoms over a 30-day treatment period.  This Phase-II-A, single-center, open-label, therapeutic exploratory clinical trial was conducted on 20 patients diagnosed with obesity-related conditions. Participants were administered 1-2 DELIPO CAPSULES twice daily with lukewarm water for 30 days. Clinical and laboratory assessments were performed at baseline (day-1) and post-treatment (day-30). Ethical approval was obtained, and written informed consent was secured from all participants.

Results: After 30 days of treatment: 75% (15 patients) experienced significant symptom improvement. 15% (3 patients) showed moderate improvement. 5% (1 patient) had mild improvement. 5% (1 patient) dropped out of the study. Laboratory investigations confirmed improvements in cholesterol levels and metabolic markers.

Conclusion: DELIPO CAPSULE demonstrated significant efficacy in managing obesity-related symptoms and metabolic imbalances. The findings support its potential as a safe and effective Ayurvedic intervention for weight management and hypercholesterolemia.
Keywords: Obesity, Hypercholesterolemia, Metabolic disorders, Ayurvedic medicine
Received on 29th January 2025; Revised on 18th   February 2025; Accepted on 28th February 2025, DOI:10.36678/IJMAES.2025.V11I01.002

Leave a Reply

Your email address will not be published. Required fields are marked *

  Posts

1 … 8 9 10 … 43
October 19th, 2026

Why Internet Gamblers Are Shifting to International Gaming Platforms

The environment of internet casinos has experienced a major change in recent years, with non GamStop casinos emerging as one […]

October 18th, 2026

Finding Trustworthy Low Minimum Deposit Casinos for New Players

For newcomers starting out in online gambling, UK casino sites offer an easy starting option without requiring significant financial investment. […]

October 17th, 2026

Understanding Curacao Gambling License Requirements for Internet Gaming Operators in 2024

The online casino industry continues to expand globally, and securing appropriate licenses remains a essential requirement for operators aiming to […]

October 17th, 2026

Comparing Self-Exclusion Tools vs Other Options: Discovering the Optimal Safeguards for You

When gambling turns problematic, self-exclusion tools offer a critical safeguard to help individuals regain control. With new non GamStop casinos […]

October 17th, 2026

Exploring the regulatory framework of offshore gaming sites in the UK Go back to homepage to the main area

The growth of internet gaming has encouraged many UK players to consider offshore platforms, raising important questions about the slot […]

October 17th, 2026

How Fast Withdrawal Times Impact Your Internet Gaming Journey

When it involves online casino gaming, few factors influence player satisfaction as significantly as non GamStop casino UK. The time […]

October 17th, 2026

Why Certain Players Opt for Offshore Operators Beyond UKGC Licensing In Today’s Market

The UK gaming industry has witnessed a notable shift as more participants consider not on GamStop licensing, seeking alternatives to […]

October 17th, 2026

Grasping Slot Machine RTP Standards and Their Influence on Payouts to Players

Understanding non GamStop casino is essential for casino enthusiasts looking to enhance their play sessions and evaluate options about where […]

October 17th, 2026

How Open Banking Revolutionizes Casino Deposits for Quicker More Secure Transactions

The online transaction landscape is rapidly evolving, and best casinos not on GamStop constitute one of the most important innovations […]

October 17th, 2026

Warning indicators That Reveal You’re Wagering at a Fraudulent gambling site

Online gambling offers excitement and potential rewards, but not all casinos operate with integrity. Identifying casinos without GamStop is essential […]